NeuroVigil closed a $6 billion Series B deal with 27 strategic investors, valuing the company at over $6 billion

Apr 06, 2024•over 1 year ago

Amount Raised

$85 Million

Round Type

series b

San FranciscoBiotechnologyHealth Care

Investors

7 Top Law Firms5 Pioneering Clinics3 Elite VcsAmerican Super AngelLeading UniversityMajor Hospital

Description

NeuroVigil has closed a $6 billion Series B deal, marking the highest Series B financing in history. The funding round included 27 strategic investors and valued the company at over $6 billion. The company's non-invasive iBrain™ Personal Brain Monitor has been launched in 4 US states with plans for further development and applications.

Company Information

Company

NeuroVigil

Location

San Francisco, California, United States

About

Silicon Valley-based Neurotechnology Powerhouse, NeuroVigil focuses on developing non-invasive brain technology to monitor brain activity and detect potential health issues. The company holds numerous patents in the field of neurotechnology and has secured partnerships with major pharmaceutical companies for research and development.

Related People

1 contact

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends